Fred Alger Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-544,408
Closed -$6.27M 459
2025
Q2
$6.27M Sell
544,408
-192,445
-26% -$2.28M 0.03% 206
2025
Q1
$11M Buy
736,853
+180,344
+32% +$3.02M 0.06% 160
2024
Q4
$9.63M Buy
556,509
+20,596
+4% +$397K 0.05% 183
2024
Q3
$9.93M Sell
535,913
-8,238
-2% -$165K 0.05% 184
2024
Q2
$11M Sell
544,151
-318,121
-37% -$5.63M 0.05% 183
2024
Q1
$14.7M Sell
862,272
-158,277
-16% -$2.49M 0.07% 167
2023
Q4
$18M Sell
1,020,549
-306,780
-23% -$6.18M 0.1% 146
2023
Q3
$31.9M Sell
1,327,329
-1,401,417
-51% -$34.4M 0.18% 115
2023
Q2
$63.4M Sell
2,728,746
-853,758
-24% -$19.3M 0.32% 87
2023
Q1
$79M Sell
3,582,504
-271,473
-7% -$6.35M 0.42% 67
2022
Q4
$78.1M Sell
3,853,977
-235,347
-6% -$4.56M 0.42% 73
2022
Q3
$55.1M Buy
4,089,324
+64,734
+2% +$1.09M 0.28% 99
2022
Q2
$79.7M Sell
4,024,590
-206,338
-5% -$5.48M 0.37% 83
2022
Q1
$134M Buy
4,230,928
+211,693
+5% +$5.93M 0.43% 72
2021
Q4
$89.7M Sell
4,019,235
-1,119,904
-22% -$29.2M 0.22% 122
2021
Q3
$143M Sell
5,139,139
-723,127
-12% -$22M 0.34% 91
2021
Q2
$228M Buy
5,862,266
+2,668,618
+84% +$95.7M 0.54% 59
2021
Q1
$91.9M Buy
3,193,648
+829,502
+35% +$28.3M 0.24% 124
2020
Q4
$62.7M Buy
2,364,146
+1,057,696
+81% +$21.6M 0.16% 137
2020
Q3
$19.9M Buy
1,306,450
+1,223,710
+1,479% +$25.7M 0.06% 165
2020
Q2
$1.68M Buy
+82,740
New +$1.48M 0.01% 316
2019
Q4
Sell
-55,200
Closed -$2.57M 490
2019
Q3
$2.57M Hold
55,200
0.01% 267
2019
Q2
$2.89M Buy
55,200
+4,400
+9% +$258K 0.01% 274
2019
Q1
$3.5M Buy
50,800
+10,800
+27% +$724K 0.01% 254
2018
Q4
$2.39M Buy
+40,000
New +$3.45M 0.01% 271

Other funds holding CLB

Fred Alger Management's CLB Position: Q3 2025 in Review

Fred Alger Management sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 544,408 shares — an estimated $6.27M sold.

Fred Alger Management first reported a position in CLB in Q4 2018 and held it in 25 quarters. The position peaked at $228M in Q2 2021. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Fred Alger Management reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
  • Fred Alger Management sold 544,408 Core Laboratories shares in Q3 2025, an estimated $6.27M.
  • Fred Alger Management first reported a position in Core Laboratories in Q4 2018 and held it in 25 quarters.
  • Fred Alger Management's Core Laboratories position peaked at $228M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Fred Alger Management's 13F filing for Q3 2025, filed 14 Nov 2025.